Combined synopsis and solicitation
Seqirus (or equal) seasonal influenza vaccine doses to FDA Occupational Health Units (OHUs) at the White Oak Campus in Silver Spring, MD, and the Jefferson Laboratories Campus in Jefferson, AR
75F40125Q130864
Food and Drug Administration, FDA Office of Acq Grant SVCS. Pharmaceutical Preparation Manufacturing.
Awarded
$91,155.00 obligated so far on USAspending
Get the next one like this from Food and Drug Administration by email, the day it is posted.Find my opportunities
This one was awarded in 2025
9 like it are open now in pharmaceutical preparation manufacturing
- FY27 Low Energy General Radiopharmaceuticals 36C25027Q0052
Department of Veterans Affairs, 250-Network Contract Office 10
Sources soughtNAICS 325412Anywhere in the US36C25027Q0052Closes tomorrowNov 3 - Sacubitril/Valsartan Tablets (VA-27-00014055)
Department of Veterans Affairs, Nac Pharmaceuticals
PresolicitationNAICS 325412Anywhere in the US36E79727R0007Closes tomorrowNov 3 - LIDOCAINE 5% PATCHES-REQUEST FOR INFORMATION
Department of Veterans Affairs, National Cmop Office
Sources soughtNAICS 325412Anywhere in the US36C77027Q0010Closes tomorrowNov 3
Description
As published on SAM.gov.
UPDATE 08/05/2025: This update is to post another question and response thereto, and to post an amendment addressing all changes resulting from those questions. See attached Amendment A00001. The closing date for this RFQ is not changed.
Question #4: "Does the FDA require delivery of the vaccines all at once or as the product becomes available with final delivery by 09/30/2025?" Response: Vaccines are required to be delivered anytime after contract award; however, all vaccines (100%) must arrive to the destination locations no later than by September 30, 2025. UPDATE 08/01/2025: This posting is updated to reflect a quote due date of August 7, 2025, NOT August 5th, 2025. This update is also to post Q&As that have been received, along with the Government's responses:
Question #1: "Is the volume requested in units or doses? Noting, each unit of influenza vaccine across all manufacturers represent 10 doses" Response: "We are seeking doses of Flucelvax and 1,00 doses of FLUAD (or equal)." Question #2: "Under the Requirement and Background on page 2, it states that the product should be FLUAD and Flucelvax.
Is the requirement only to be a single-dose pre-filled syringe formulated for adults 65 years of age and older (similar to FLUAD) and a single-dose pre-filled syringe formulated for adults under 65 years of age (similar to Flucelvax)? Is the US FDA seeking an egg-free presentation." Response: "We are seeking pre-filled syringes however, not specifically seeking an egg-free presentation." Question #3: "Is the due date for responses August 5th or August 7th? Solicitation indicates the 7th but SAM says the 5th."
Response: "Quotes are due the 7th of August, as per the solicitation. SAM has been updated to reflect that, too." ORIGINAL: See attached Solicitation/Request for Quote (RFQ) for Flu Vaccines for the Food and Drug Administration.
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- Recipient
- Seqirus USA Inc.
- UEI
- N6U7P2B9VHS5
- CAGE
- 530P3
- Vendor location
- Summit, NJ
- Contract
- 75F40125P00169, purchase order
- Obligated
- $91,155.00
- Actions
- 1 between August 13, 2025 and August 13, 2025
- Competition
- Competed Under SAP, 5 offers received
- Set-aside reported
- No Set Aside Used.
- Described as
- Flu Vaccines for the FDA Immunization Program
- Match
- solicitation number 75F40125Q130864 equals the FPDS solicitation identifier; same awarding office 75F401 (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
July 31, 2025
Combined synopsis and solicitation, originally sources sought
Due August 5, 2025 at 3:00 PM EDT. SAM.gov, notice f88edcc7721e440e8203d7cb1ef753b7
August 1, 2025
Combined synopsis and solicitation
Due August 7, 2025 at 3:00 PM EDT. SAM.gov, notice a95563b5cd9e4fd09ec26f9633a31e08
August 5, 2025
Combined synopsis and solicitation
Due August 7, 2025 at 3:00 PM EDT. SAM.gov, notice 65c293d621bd49dbb11d5bc68c30819c
Points of contact
- Suzanne Martellasuzanne.martella@fda.hhs.gov8705437540